Philips vs Broadcom
Side-by-side comparison of AI visibility scores, market position, and capabilities
Dutch health technology company with €17B revenue; MRI/CT imaging and patient monitoring managing massive sleep apnea device recall competing with Siemens Healthineers and GE HealthCare.
About
Philips is a Dutch multinational technology and health technology company that has transformed from a broad consumer electronics conglomerate into a focused health technology leader — producing diagnostic imaging systems (MRI, CT, ultrasound), patient monitoring, hospital informatics, personal health products (electric toothbrushes, shavers, sleep apnea devices), and health informatics solutions. Listed on the Amsterdam Stock Exchange (AEX: PHIA) and headquartered in Amsterdam, Philips generates approximately €17 billion ($18 billion) in annual revenue after divesting its lighting division (now Signify) and domestic appliances business.\n\nPhilips' health technology portfolio spans two segments: Diagnosis & Treatment (imaging systems, image-guided therapy, and ultrasound for hospitals) and Connected Care (patient monitoring, respiratory care, sleep therapy). The Diagnosis & Treatment segment provides MRI systems, CT scanners, and X-ray equipment to hospitals globally. The Connected Care segment includes Philips' DreamStation and other sleep apnea (CPAP/BiPAP) devices, home respiratory care, and hospital patient monitoring platforms.\n\nIn 2025, Philips is managing the severe consequences of a 2021 recall of approximately 5.5 million sleep apnea devices (Philips Respironics DreamStation and related models) due to concerns that degraded polyester foam could release harmful particles and gases — one of the largest medical device recalls in history. The recall has resulted in multi-billion dollar settlements, regulatory scrutiny, and significant reputation damage in the sleep therapy market, allowing competitors ResMed and Fisher & Paykel to gain share. Philips' 2025 strategy focuses on resolving recall liabilities, rebuilding the sleep therapy business, and investing in AI-powered diagnostic imaging to compete with Siemens Healthineers and GE HealthCare.
Palo Alto semiconductor + infrastructure software (NASDAQ: AVGO) at $51.6B FY2024 revenue; AI revenue $12.2B (+220%) from custom XPUs and networking with VMware $69B 2023 acquisition competing with NVIDIA for AI data center infrastructure.
About
Broadcom Inc. is a Palo Alto, California-headquartered global semiconductor and infrastructure software company — publicly traded on NASDAQ (NASDAQ: AVGO) at approximately $800 billion market capitalization — reporting $51.6 billion in fiscal year 2024 revenue (ended October 2024, 44% year-over-year growth) with AI-related revenue reaching $12.2 billion (220% growth) from custom AI accelerators (XPUs) and networking chips for hyperscale cloud providers. Following the $69 billion VMware acquisition completed in November 2023 (the largest enterprise technology acquisition ever), Broadcom's revenue is now 58% semiconductor and 42% infrastructure software (VMware by Broadcom, CA Technologies products, and Symantec enterprise security). Under CEO Hock Tan's acquisition-driven strategy since 2006, Broadcom has transformed from a moderate-sized fabless semiconductor company into a diversified technology powerhouse with 37,000+ employees. Roots trace to HP Associates (1961), then Agilent Technologies, then Avago Technologies, which acquired Broadcom Corporation in 2016.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.